Stocks
Applied Therapeutics (APLT) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -45.6 | -94.5 | -105.2 | -82.1 | -64.5 | -92.3 | ||
| Changes by years, y/y, % | +243% | +107% | +11% | -22% | -21% | +37.2% | |||
Applied Therapeutics. EBITDA US GAAP, bln rub
Applied Therapeutics. EBITDA US GAAP, changes, %
Applied Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Applied Therapeutics (APLT) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -15.5 | -21.0 | -21.1 | -20.4 | -29.7 | -92.3 | |
| Changes by years, y/y, % | -20% | -9% | +86% | +380% | +92% | |||
| Changes by quarters, q/q, % | +264% | +36% | +0% | -3% | +46% | |||
